Roivant Sciences Ltd. annual net income for fiscal 2026 was -$300 million, a decrease of 74.3% from -$172 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Net Income (annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Net Income | ($300M) | ($172M) | $4.3B | ($1.0B) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Net Income (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Net Income | $303M | ($266M) | ($114M) | ($223M) | ($206M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ROIV metrics: Revenue · Gross Profit · Operating Income · EPS · Free Cash Flow
All ROIV financial statements → Interactive ROIV charts →
About TickerBase · Data methodology & sources